Your browser doesn't support javascript.
Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society.
Kosior, Dariusz A; Undas, Anetta; Kopec, Grzegorz; Hryniewiecki, Tomasz; Torbicki, Adam; Mularek-Kubzdela, Tatiana; Windyga, Jerzy; Pruszczyk, Piotr.
  • Kosior DA; Mossakowski Medical Research Centre Polish Academy of Science, Warsaw, Poland; Department of Cardiology and Hypertension with the Electrophysiological Lab, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland. dariusz.kosior@cskmswia.pl
  • Undas A; Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland
  • Kopec G; Department of Cardiac and Vascular Diseases, John Paul II Hospital, Jagiellonian University Medical College, Kraków, Poland
  • Hryniewiecki T; Department of Acquired Cardiac Defect, Institute of Cardiology, Warsaw, Poland
  • Torbicki A; Department of Pulmonary Circulation and Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre, ECZ-Otwock, Poland
  • Mularek-Kubzdela T; 1st Department of Cardiology, Poznan University of Medical Sciences, Poznan, Poland
  • Windyga J; Department of Hemostasis Disorders and Internal Medicine Laboratory of Hemostasis and Metabolic Diseases Institute of Hematology and Transfusion Medicine, Warsaw, Poland
  • Pruszczyk P; Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland
Kardiol Pol ; 78(6): 642-646, 2020 06 25.
Article in English | MEDLINE | ID: covidwho-701600
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic affects anticoagulation not only in those infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) but also in most patients who require daily anticoagulant therapy and are facing substantial limitations in medical care these days. Concomitant venous thromboembolism (VTE), a potential cause of unexplained deaths, has frequently been reported in patients with COVID-19, but its management is still challenging due to the complexity between antithrombotic therapy and hematological alterations. In the era of COVID-19 pandemic, it is highly recommended for patients who require chronic anticoagulation to continue therapy to prevent thromboembolic events. To avoid regular and frequent blood tests and unnecessary exposure to SARS-CoV-2 during contacts with medical personnel, direct oral anticoagulants should be strongly preferred whenever possible. Current evidence is insufficient to recommend routine pharmacological antithrombotic prophylaxis in all hospitalized patients with COVID-19. In patients with COVID-19 who are suspected of VTE or in whom the diagnosis is confirmed, parenteral therapy with low-molecular-weight heparin should be initiated in the absence of contraindications. If heparin-induced thrombocytopenia is suspected, nonheparin anticoagulants should be used such as bivalirudin or fondaparinux. In case of confirmed acute pulmonary embolism, treatment should be guided by risk stratification as defined in the current guidelines.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Practice Guidelines as Topic / Coronavirus Infections / Expert Testimony / Venous Thromboembolism / Anticoagulants Type of study: Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Kardiol Pol Year: 2020 Document Type: Article Affiliation country: KP.15425

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Practice Guidelines as Topic / Coronavirus Infections / Expert Testimony / Venous Thromboembolism / Anticoagulants Type of study: Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Europa Language: English Journal: Kardiol Pol Year: 2020 Document Type: Article Affiliation country: KP.15425